A Study of YTS109 Cell Injection in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia

Clinical trial NCT06770504 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06770504
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Hemolytic Anemia Anti-CD19 STAR T-cell Therapy Failure ≥3 Lines of Therapies

Start date: 2025-01-16
Primary completion: 2025-12-30
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.